Lecture 7 Flashcards

Cannabis

1
Q

Cannabinoids

A

Compounds made by the cannabis plant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Things that act on the human cannabinoid receptors (6)

A

○ Phyto cannabinoids
○ Delta9 tetrahydrocannabinol (THC)
○ CBD
○ Endo cannabinoids
○ Anandamide
○ 2AG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CBD has been investigated because

A

it does not cause an euphoric high, but may have health benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

___ is the most abundant in the brain

A

2AG
- More than anandamide but they both perform the same function
- Agonists of the CB1 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What activates CB1 receptors

A

Endocannabinoids, and THC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the most abundant G protein coupled receptor in the brain

A

CB1 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CB1 receptors are also widely expressed in

A

the body
- lungs, liver, kidney, pancreas, and bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CB2 receptors are expressed

A

in the brain at lower levels. They are often thought of as “peripheral cannabinoid receptors” because they are more highly expressed in the body than the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CB2 receptors are activated by

A

THC and endocannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cannabinoid system is like

A

the brain’s equalizer, modulating the intensity of every neuronal signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where else are CB2 receptors found

A

immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what makes endocannabinoids

A

postsynaptic neurons
- eCBs are made by enzymes that convert membrane lipids into eCBs.
- The eCBs diffuse out and bind to the nearby CB1 receptors on presynaptic neurons (at axon terminal).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The eCBs are quickly degraded by

A

other enzymes so they act for a very short time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When eCBs bind to the CB1 receptor,

A

they activate the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The CB1 receptor activation causes the presynaptic neuron to

A

release LESS neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Endocannabinoids characteristics

A

○ Quickly degraded –fast acting
○ modulators to correct level of neurotransmission
○ Appetite stimulant
○ Reduces pain (part of descending pathway)
○ Promotes learning & memory
○ Promotes bone formation

17
Q

characteristics of THC

A

○ Long-lasting – acute effects last for hours, accumulates in fat tissues and remains in body for weeks
○ Appetite stimulant & anti-emetic
○ Reduces pain (analgesic) and muscle spasticity
○ Impairs learning & memory
○ Hallucinations (sensory & time distortion)
○ Psychosis

18
Q

acute effects of cannabis

A
  • Euphoria – high
  • Analgesia
  • Sleepiness
  • Reduces anxiety (but causes anxiety in some people)
  • Hallucinations & time distortion
  • Reduces nausea (but can cause excessive vomiting in some people)
  • Increased appetite
  • Fatal overdose rare (accidents can occur while intoxicated)
19
Q

Effects of chronic cannabis consumption

A
  • Tolerance to effects – dose escalation
  • Physical dependence and withdrawal
  • Cannabis use disorder - addiction
  • Withdrawal symptoms: agitation, anger, depression, insomnia, loss of appetite, weight loss, headache, nausea, vomiting, sweating, strange/upsetting dreams
20
Q

THC is prescribed with the drug name

A

dronabinol (marinol)

21
Q

THC is approved to treat

A

anorexia in HIV/AIDS, treat nausea and vomiting induced by chemotherapy

22
Q

nabilone is a synthetic analog of

A

THC

23
Q

Nabilone is approved to treat

A

anorexia with AIDS, nausea and vomiting from chemo

24
Q

THC and CBD mixed medication is called

A

Nabiximol (Sativex) - mouth spray

25
Q

what is Nabiximol used for

A
  • Used for MS, white matter tracks are losing their myelination and there is no balanced contraction of muscles
  • Reduces muscle spasticity and pain that accompanies multiple sclerosis.
  • Reduces pain in cancer patients.
26
Q

Medical uses of CBD

A

for Dravet Syndrome (childhood onset epilepsy) (not for other forms)

27
Q

what is the medical drug name for the CBD medication for Dravet

A

epidiolex

28
Q

what else is epidiolex being tested for treatment for

A

chronic pain and inflammatory disorders

29
Q

cannabis and psychosis

A
  • cannabis is associated with increased risk of experiencing schizophrenia
  • early cannabis use (15 yo) confers greater risk for schizophrenia
  • risk was specific to cannabis use, and early cannabis use did not predict later depression
30
Q

is Cannabis addictive

A
  • Cannabis use disorder (cannabis addiction) and cannabis withdrawal are now part of the DSM-V.
  • Daily cannabis use leads to tolerance (downregulation of CB1 receptors), dependence & withdrawal.
  • People who seek treatment for cannabis use disorder have usually been smoking for several years (10+) and have tried unsuccessfully to quit multiple times.
31
Q

Withdrawal symptoms of Cannabis

A

Withdrawal symptoms (may take weeks to subside): depression & anxiety, insomnia, GI disturbances, reduced appetite.

32
Q

CB1 receptor antagonist

A

rimonabant

33
Q

what was rimonabant

A

tldr: proposed treatment for drugs treating schizophrenia and bipolar but it didnt work
- THC in cannabis increases appetite. Would CB1 receptor antagonist reduce appetite? This could be a good treatment to aid weight loss with obesity.
- Since CB1 agonists like THC can cause psychosis, would a CB1 antagonist be an antipsychotic?
- Current treatments for schizophrenia and bipolar disorder cause weight gain, so a treatment that reduces psychosis and weight gain could be a substantial improvement for therapy.
- Several CB1 antagonists were developed by different pharmaceutical companies and were in clinical trials for weight loss.
- Rimonabant was approved in EU in 2005. It reduced food intake and promoted weight loss.
- Unfortunately, it also caused suicidal ideation and Sanofi-Aventis discontinued the production of the medicine in 2008. Merck and Pfizer also halted their programs.